CAS 68547-97-7

Formel: C6H10ClNO2

InChl: InChI=1S/C6H9NO2.ClH/c8-6(9)5-1-3-7-4-2-5;/h1,7H,2-4H2,(H,8,9);1H

InChI Key: SUWREQRNTXCCBL-UHFFFAOYSA-N

SMILES: C1CNCC=C1C(=O)O.Cl

1,2,3,6-Tetrahydro-4-pyridinecarboxylic Acid Hydrochloride

CAS: 68547-97-7

Formel: C₆H₁₀ClNO₂

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 163.6021

Ref: IN-DA0032K2

Isoguvacine hydrochloride

CAS: 68547-97-7

Isoguvacine hydrochloride (1,2,3,6-tetrahydro-4-pyridinecarboxylic acid hydrochloride) is a GABA receptor agonist.

Formel: C₆H₁₀ClNO₂

Reinheit: 99.59%

Farbe und Form: Solid

Molekulargewicht: 163.6

Ref: TM-T11684

Isoguvacine hydrochloride

CAS: 68547-97-7

Formel: C₆H₉NO₂·HCl

Reinheit: ≥ 98.0%

Farbe und Form: White solid

Molekulargewicht: 163.60

Ref: 7W-GL2705

Isoguvacine hydrochloride

CAS: 68547-97-7

Isoguvacine hydrochloride

Formel: C₆H₁₀ClNO₂

Reinheit: ≥98%

Molekulargewicht: 163.6

Ref: 54-BUP11846

1,2,3,6-Tetrahydro-4-Pyridinecarboxylic Acid Hydrochloride

CAS: 68547-97-7

1,2,3,6-Tetrahydro-4-Pyridinecarboxylic Acid Hydrochloride

Formel: C₆H₁₀ClNO₂

Reinheit: 95%

Molekulargewicht: 163.6

Ref: 54-OR1027314

Isoguvacine Hydrochloride

CAS: 64603-90-3, 68547-97-7

Formel: C₆H₉NO₂·HCl

Reinheit: >98.0%(HPLC)

Farbe und Form: Light orange to Yellow to Green powder to crystal

Molekulargewicht: 163.60

Ref: 3B-I0871

Isoguvacine HCl

CAS: 68547-97-7

1,2,3,6-Tetrahydro-4-pyridinecarboxylic Acid Hydrochloride

Formel: C₆H₁₀ClNO₂

Reinheit: 95%

Molekulargewicht: 163.6

Ref: IN-DG223448

1,2,3,6-Tetrahydro-pyridine-4-carboxylic acid hydrochloride

CAS: 68547-97-7

Formel: C₆H₁₀ClNO₂

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 163.6

Ref: 10-F041827

Isoguvacine hydrochloride

CAS: 68547-97-7

Isoguvacine is an alkaloid that belongs to the group of pharmacological agents. It has been shown to have a synergic effect with other drugs, such as 5-HT2 receptor antagonists and 5-HT3 receptor antagonists, at the level of the plate test. Isoguvacine inhibits the cyclase enzyme, which catalyzes the conversion of ATP into cAMP. The inhibition leads to a decrease in cAMP levels and consequently a decrease in intracellular calcium levels. This drug also blocks glutamate receptors on neurons, preventing their activation by glutamate.

Formel: C₆H₉NO₂•HCl

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 163.6 g/mol

Ref: 3D-TCA54797